Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PACRITINIB vs PANCRELIPASE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PACRITINIB vs PANCRELIPASE: Safety Overview

Metric PACRITINIB PANCRELIPASE
Total FAERS Reports 2,563 724
Deaths Reported 292 66
Death Rate 11.4% 9.1%
Hospitalizations 455 281
Average Patient Age 71.8 yrs 52.0 yrs
% Female Patients 45.1% 50.4%
FDA Approval Date Feb 28, 2022 N/A
Manufacturer Sobi, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued